Apotex Inc.
Kajal Palan, MBA, currently serves as the VP Finance & Strategy for Apotex Global Operations since July 2016, where previous roles included Sr. Director of Operations Finance & Strategy and Director Finance for Global Supply & Manufacturing. Before joining Apotex Inc., Kajal held the position of Director of Finance at Piramal Pharma Solutions, overseeing accounting functions and budget preparation, and also played a strategic role in the divestment of a business unit. Earlier experience includes serving as Director of Finance at Ontario Genomics Institute, where financial leadership and compliance were critical, and as Director of Strategic Business Initiatives and Director of Operational Finance at Mylan, focusing on market research and operational restructuring. Kajal's career began at Patheon Inc. as Senior Manager of Corporate Development. Educational qualifications include an MMA and MBA from Queen's University, along with a CPA designation from CPA Canada.
This person is not in the org chart
Apotex Inc.
3 followers
Apotex is a Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, the company has focused on research, development, manufacturing and distribution. Apotex has steadily grown to employ over 10,000 people around the world.Apotex Pharmachem is a global, fully integrated API R&Dand manufacturing organization with its headquarters located in Brantford, Ontario, and is a member of the Apotex group of companies. Apotex Pharmachem has multiple facilities around the world located in Canada, India, Mexico, and China. Learn more at www.ApotexPharmachem.com.